×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Sessions 25 and 26
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
Session 25: Beyond Approval – Post Approval Changes
- This section will drill down into the realm of post approval changes such as PAS's, CBE's, and ARs
- SUPAC documents will be discussed which are integral in the post approval world
- Components and Composition
- Manufacturing Sites and Process
- Specifications
- Container/Closure System
Have an account?